Supporting this hypothesis, Astorri et al. reported elevated serum levels of PSP in patients with both newly diagnosed and long-standing diabetes (type 1 and type 2), while anti-PSP antibodies were detected exclusively in individuals with type 1 diabetes. This evidence concerns the gene REG1A and type 1 diabetes mellitus.